{
"NDC": {
"NDCCode": "83012-011-10",
"PackageDescription": "1 mL in 1 SYRINGE (83012-011-10) ",
"NDC11Code": "83012-0011-10",
"ProductNDC": "83012-011",
"ProductTypeName": "DRUG FOR FURTHER PROCESSING",
"ProprietaryName": null,
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Adalimumab",
"DosageFormName": "LIQUID",
"RouteName": null,
"StartMarketingDate": "20240430",
"EndMarketingDate": null,
"MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
"ApplicationNumber": null,
"LabelerName": "Boehringer Ingelheim Fremont, Inc.",
"SubstanceName": "ADALIMUMAB-ADBM",
"StrengthNumber": "40",
"StrengthUnit": "mg/.4mL",
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Unfinished",
"LastUpdate": "2025-03-26",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": null,
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "30-APR-24",
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}